Peder Sven Walberg
Director/Board Member at EGETIS THERAPEUTICS AB
Net worth: 20 M $ as of 2024-04-29
Network origin in Peder Sven Walberg first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
34
| Public Company | Pharmaceuticals: Major | 34 |
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Pharmaceuticals: Major | 11 | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.
7
| Holding Company | Pharmaceuticals: Generic | 7 |
Immedica Pharma AB
 Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden.
7
| Holding Company | Medical Distributors | 7 |
| Subsidiary | Pharmaceuticals: Major | 6 | |
Immedica Pharma Holding AB
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Peder Sven Walberg via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Graduate Degree Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin Doctorate Degree Masters Business Admin Masters Business Admin | |
| University of Uppsala | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Masters Business Admin Undergraduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Public Communications Contact Investor Relations Contact Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Human Resources Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO Chief Executive Officer | |
| Karolinska Institutet | College/University | Director/Board Member Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Gothenburg | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Operating Officer | |
Impilo AB
 Impilo AB Investment ManagersFinance Impilo AB (Impilo) is an independent private equity firm founded in 2016 by Sören Mellstig. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director of Finance/CFO Director/Board Member General Counsel | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Corporate Officer/Principal Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Private Equity Investor | |
| University of Basel | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Stockholm | College/University | Undergraduate Degree Masters Business Admin | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Lund | College/University | Undergraduate Degree Graduate Degree | |
Hi3G Access AB
 Hi3G Access AB Specialty TelecommunicationsCommunications Hi3G Access AB provides mobile communication services. It offers cellular phone services, paging services, wireless Internet access, and wireless video services. The company was founded in December 2000 and is headquartered in Stockholm, Sweden. | Specialty Telecommunications | Director/Board Member Director/Board Member | |
Novartis Consumer Health, Inc.
 Novartis Consumer Health, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Novartis Consumer Health, Inc. manufactures and supplies pharmaceutical products. The company is based in Lincoln, NE. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman General Counsel | |
| OREXO AB | Pharmaceuticals: Major | Chairman Chairman | |
SIX Swiss Exchange AG
 SIX Swiss Exchange AG Investment Banks/BrokersFinance SIX Swiss Exchange AG operates as a stock exchange. It distributes a range of indices; and offers market data for shares, bonds, ETFs and funds, ETPs, indices, statistics, and data services. The firm enables to list and trade in segments, including equities, bonds, exchange traded funds (ETFs), exchange traded products (ETPs), derivatives, sponsored funds, sponsored foreign shares, warrants, and structured products. The company was founded in 1850 and is headquartered in Zurich, Switzerland. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Chairman | |
| University of Zurich | College/University | Doctorate Degree Masters Business Admin | |
| University of Cambridge | College/University | Undergraduate Degree Doctorate Degree | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
| University of Delaware | College/University | Undergraduate Degree Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
| ALCON INC. | Medical Specialties | Director/Board Member Chief Executive Officer | |
| SYNGENTA | Chemicals: Agricultural | Director/Board Member Chief Tech/Sci/R&D Officer | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Investor AB (Investment Company)
 Investor AB (Investment Company) Financial ConglomeratesFinance Investor AB (Investment Company) (Investor-IC) is the investment division of Investor AB (STO: INVE-B; LSE: INU), a Swedish public company established in 1916 as the investment vehicle for the Wallenberg family, which still owns a significant part of the firm. Investor AB is an industrial holding company which manages private equity funds listed on the Swedish stock exchange. Headquartered in Stockholm, Investor-IC is a socially responsible investor which supports the OECD Guidelines for Multinational Enterprises, including anti-corruption and human rights. They are committed to the development of society at large and sponsor youth, education and entrepreneurship activities. | Financial Conglomerates | Chief Investment Officer Chief Investment Officer | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Director of Investments Comptroller/Controller/Auditor |
Statistics
International
| Sweden | 25 |
| United States | 12 |
| Switzerland | 9 |
| United Kingdom | 3 |
| Denmark | 3 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 14 |
| Finance | 6 |
| Commercial Services | 5 |
| Communications | 2 |
Operational
| Director/Board Member | 521 |
| Corporate Officer/Principal | 216 |
| Chairman | 167 |
| Independent Dir/Board Member | 123 |
| Chief Executive Officer | 85 |
Most connected contacts
| Insiders | |
|---|---|
| Erling Lennart Johansson | 64 |
| Thomas Lennart Eklund | 57 |
| Adine Charlotte Grate Axén | 39 |
| Bo Jesper Hansen | 34 |
| Georges Gemayel | 33 |
| Thomas Ebeling | 33 |
| Joseph Jimenez | 32 |
| Stig Lennart Hansson | 32 |
| Alf Gunnar Martin Nicklasson | 31 |
| Rémi Droller | 29 |
| Khalid Islam | 29 |
| Håkan Åström | 26 |
| Jeffrey George | 25 |
| Andreas von Planta | 24 |
| Erika Kjellberg-Eriksson | 23 |
- Stock Market
- Insiders
- Peder Sven Walberg
- Company connections
